Galectin Therapeutics
Earnings Surprise
Analysts estimated GALT earnings of $-0.10 per share this quarter (Q4). GALT's actual earnings were $-0.08 per share.
GALT EPS surprise of 21.57%Analysts estimated GALT earnings of $-0.11 per share this quarter (Q3). GALT's actual earnings were $-0.13 per share.
GALT EPS surprise of -15.86%Analysts estimated GALT earnings of $-0.16 per share this quarter (Q2). GALT's actual earnings were $-0.12 per share.
GALT EPS surprise of 26.47%Analysts estimated GALT earnings of $-0.20 per share this quarter (Q1). GALT's actual earnings were $-0.15 per share.
GALT EPS surprise of 26.47%Analysts estimated GALT earnings of $-0.16 per share this quarter (Q4). GALT's actual earnings were $-0.19 per share.
GALT EPS surprise of -16.42%Analysts estimated GALT earnings of $-0.20 per share this quarter (Q3). GALT's actual earnings were $-0.18 per share.
GALT EPS surprise of 11.76%Analysts estimated GALT earnings of $-0.16 per share this quarter (Q2). GALT's actual earnings were $-0.20 per share.
GALT EPS surprise of -22.55%Analysts estimated GALT earnings of $-0.16 per share this quarter (Q1). GALT's actual earnings were $-0.19 per share.
GALT EPS surprise of -16.42%Analysts estimated GALT earnings of $-0.16 per share this quarter (Q3). GALT's actual earnings were $-0.24 per share.
GALT EPS surprise of 47.06%